22 August 2024
22 August 2024
Following the 510(k) clearance l of Maui’s K3900 imaging device, the company has now announced a partnership with the US Army to advance trauma medicine.
As more smartwatch brands receive regulatory clearance, users will be able to choose this approach before visiting sleep clinics.
A prototype has already been developed that could be affixed to the pancreas during surgery to target residual cancer cells.
The AI-powered system is designed for improved efficiency and consistency for the therapy.
ProSpectral is a portable, reagent-free bench-top hyperspectral instrument designed to be used with clinical samples.
The system is compatible with bone screws and lateral MIS anchors and provides procedural versatility for bone fixation options.
The funds will go towards a US pivotal trial and commercial launch in select European markets.
The company’s iFuse TORQ TNT Implant System has a porous implant for a “more effective” treatment for pelvic fragility fractures.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
